The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2023
Filed:
Mar. 15, 2021
Takeda Pharmaceutical Company Limited, Osaka, JP;
Yuya Oguro, Fujisawa, JP;
Shigemitsu Matsumoto, Fujisawa, JP;
Takeshi Wakabayashi, Fujisawa, JP;
Norihito Tokunaga, Fujisawa, JP;
Taku Kamei, Fujisawa, JP;
Mitsuhiro Ito, Fujisawa, JP;
Satoshi Mikami, Fujisawa, JP;
Masaki Seto, Fujisawa, JP;
Shinji Morimoto, Fujisawa, JP;
Shinji Nakamura, Fujisawa, JP;
Sachie Takashima, Fujisawa, JP;
Masataka Murakami, Fujisawa, JP;
Masaki Daini, Fujisawa, JP;
Makoto Kamata, Fujisawa, JP;
Minoru Nakamura, Fujisawa, JP;
Yasufumi Wada, Fujisawa, JP;
Hiroyuki Kakei, Fujisawa, JP;
Kazuaki Takami, Fujisawa, JP;
Taisuke Tawaraishi, Fujisawa, JP;
Jumpei Aida, Fujisawa, JP;
Kouichi Iwanaga, Fujisawa, JP;
Satoshi Yamamoto, Fujisawa, JP;
Takeda Pharmaceutical Company Limited, Osaka, JP;
Abstract
The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.